1 / 10

Netherlands Laboratory Information Exchange: IHE-NL Lab Working Group Overview

Learn about the IHE-NL Lab working group and their goals, objectives, and project plan for enhancing healthcare information exchange in the Netherlands. Discover the use-cases, stakeholders' involvement, and implementation phases towards a more efficient laboratory system.

laelr
Download Presentation

Netherlands Laboratory Information Exchange: IHE-NL Lab Working Group Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IHE-NL Lab Andries Hamster (Forcare B.V.) Presentation @ IHE Lab meeting New York

  2. IHE Lab in The Netherlands • History • Jan. 2006: National Switchboard (LSP) for exchanging healthcare information • Jun. 2007: eLAb program initiated by NICTIZ • Dec. 2007: NICTIZ invited IHE Netherlands to deliver use-case input for eLab program • IHE-NL Lab working group • Started Dec. 2007 • User chair: Edwin Boel (UMC Utrecht, dept. Microbiology) • Vendor chair: Wiggert Kalis (MIPS) • Technical chair: Andries Hamster (Forcare B.V)

  3. IHE-NL Lab Working Group Goals & Objectives • Increase awareness of IHE Lab profile among Dutch laboratory user/vendors • Develop use-cases as input to the national “eLab program” • Stakeholder commitment through active stakeholder participation

  4. High Level “Project plan” • First phase (ends mid 2008) • Develop use-cases • Second phase (ends Q1 2009) • Choose Technology (HL7 v3 (CDA), XDS) • Develop implementation guidelines • Third phase • Pilot implementation

  5. Phase 1: Use-case Scoping

  6. Phase 1: Use-case Complexity

  7. Phase 1: Selecting Use-cases

  8. Phase 1: Use-cases • Creatinine blood test • Eppstein Barr Virus blood test • Tuberculosis test • Urinary tract infection test Dutch setting/complexity • Patient is free in selecting a laboratory • Taking Dutch healthcare IT infrastructure into account

  9. External Ordering Flow Chart

  10. Next steps • Work out use-cases in actor/transaction diagrams • Taking national switchboard (LSP) into account! • Technology selection • HL7 v3 CDA as “external order” and “results” carrier • Define “template” document • Define interactions between LSP and XDS infrastructure • Aim for public demonstration in March 2009

More Related